InvestorsHub Logo
Followers 12
Posts 417
Boards Moderated 0
Alias Born 04/14/2013

Re: None

Monday, 08/15/2016 2:26:03 PM

Monday, August 15, 2016 2:26:03 PM

Post# of 328
More positive news out from "The Street.com"

Cantor Fitzgerald analyst Bryan Brokmeier believes the spotlight on Brazil will benefit a company working on treatments for the Zika virus, like Cerus (CERS) . "Although there have been new announcements of the low risks of contracting Zika during the Olympics, Zika continues to make headlines and we believe that growing awareness and fear may drive shares of companies that are involved in combating Zika higher," he wrote. "CERS offers the only FDA approved pathogen inactivation technology and was recently included in the FDA guidance document for reducing the risk of transfusion-transmission of Zika...At least 12 babies in the U.S. have been born with microcephaly and other serious brain defects caused by Zika. That compares to more than 4,000 babies born in Brazil. More importantly, peak mosquito season just passed in Brazil so most infected babies haven't yet been born - according to multiple recent articles, 40,000 infected babies are expected to be born in Brazil. In our view, a few special reports during the Olympics on Zika and the babies born with microcephaly may be sufficient to create a national outcry over the need to combat Zika in the U.S, which would further support shares of CERS."

Page 3 of 6

https://www.thestreet.com/story/13674386/3/which-stocks-are-impacted-by-the-rio-olympics.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CERS News